Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Coronavirus Infections × HuMax-IL8 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Hematologic Neoplasms 1 Coronavirus Infections 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 COVID-19 1

Interventions

Medical Marijuana 1 Losartan 1 Ivermectin 1 HuMax-IL8 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04347226 2025-05-22

Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19

Columbia University

Phase 2 Terminated

43 enrolled 14 charts

Other hematologic neoplasm

COVID-19, Coronavirus Infections, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡